These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35810144)

  • 1. PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
    Laguno M; Ugarte A; Martinez-Rebollar M; Sobrino Y; Font G; de Lazzari E; de la Mora L; Torres B; Chivite I; Riera J; Ambrosioni J; Inciarte A; Gonzalez-Cordon A; Rojas J; Cordon E; Blanco JL; Martinez E; Mallolas J
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):24-28. PubMed ID: 35810144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
    Laguno M; Ugarte A; Martinez-Rebollar M; Sobrino Y; Font G; de Lazzari E; de la Mora L; Torres B; Chivite I; Riera J; Ambrosioni J; Inciarte A; González-Cordón A; Rojas J; Cordón E; Blanco JL; Martínez E; Mallolas J
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 May; ():. PubMed ID: 34045097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience.
    Fernández Piñeiro N; Ayerdi Aguirrebengoa O; Orviz García E; González Pérez C; Vera García M; Puerta López T; Rodríguez Martín C; Lejarraga Cañas C; Perez García J; Baza Caraciolo B; González Polo M; Alcudia Pérez F; Ruiz Fernández M; Jerez Zamora N; Morales Irala D; López Centeno B; Alioto D; Martínez Sesmero JM; Estrada Pérez V; Benítez Gimenez MT; Romero Guerrero JD
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Jun; ():. PubMed ID: 38897909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
    De La Mora L; Ugarte A; Martínez-Rebollar M; De Lazzari E; García-Hernández D; Font G; De Loredo N; Solbes E; Miquel L; Blanch J; Torres B; Riera J; Chivite I; Ambrosioni J; Inciarte A; González-Cordón A; Martínez E; Blanco JL; Mallolas J; Laguno M
    AIDS Behav; 2022 Dec; 26(12):4055-4062. PubMed ID: 35732910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To whom is HIV pre-exposure prophylaxis proposed?
    Ayerdi-Aguirrebengoa O; Vera-García M; Puerta-López T; Raposo-Utrilla M; Rodríguez-Martín C; Del Romero-Guerrero J
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):299-302. PubMed ID: 27445176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behavior and drug use impact in gay, bisexual, and other men who have sex with men.
    García-Pérez JN; Cañas-Ruano E; Navarro J; Raventós B; López L; Broto C; Arando M; Barberá MJ; Descalzo V; Suanzes P; Burgos J; Curran A; Falcó V
    Med Clin (Barc); 2022 Dec; 159(12):563-568. PubMed ID: 35725636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually Transmitted Infections: Experience in a Multidisciplinary Clinic in a Tertiary Hospital (2010-2013).
    Moreno-Ribera N; Fuertes-de Vega I; Blanco-Arévalo JL; Bosch-Mestres J; González-Cordón A; Estrach-Panella T; García-de Olalla P; Alsina-Gibert M
    Actas Dermosifiliogr; 2016 Apr; 107(3):235-41. PubMed ID: 26708458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
    Ugarte A; de la Mora L; García D; Martínez-Rebollar M; de Lazzari E; Torres B; Inciarte A; Ambrosioni J; Chivite I; Solbes E; de Loredo N; Del Carlo GF; González-Cordón A; Blanco JL; Martínez E; Mallolas J; Laguno M
    Infect Dis Ther; 2023 Feb; 12(2):425-442. PubMed ID: 36520330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montréal, Canada (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Trottier C; Vaziri M; Thomas R; Maheu-Giroux M
    Drug Alcohol Depend; 2021 Sep; 226():108875. PubMed ID: 34218004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement.
    Ahaus P; Schmidt AJ; Skaletz-Rorowski A; Uhrmacher M; Serova K; Kayser A; Wach J; Nambiar S; Brockmeyer NH; Potthoff A
    J Infect Public Health; 2022 Sep; 15(9):955-960. PubMed ID: 35926293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation models and access to HIV pre-exposure prophylaxis in Spain.
    Mir JF; Mazarío MF; Coll P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 May; 38(5):234-237. PubMed ID: 31279586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.
    Sewell J; Cambiano V; Miltz A; Speakman A; Lampe FC; Phillips A; Stuart D; Gilson R; Asboe D; Nwokolo N; Clarke A; Hart G; Rodger A
    Sex Transm Infect; 2018 Nov; 94(7):494-501. PubMed ID: 29700052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
    AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year.
    Wang Z; Mo PKH; Ip M; Fang Y; Lau JTF
    BMC Infect Dis; 2020 Apr; 20(1):299. PubMed ID: 32321442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.
    Bull L; Dimitrijevic P; Beverley S; Scarborough A; Mandalia S; Dosekun O; Barber T; Reeves I; McCormack S; Rayment M
    Int J STD AIDS; 2018 Apr; 29(5):435-442. PubMed ID: 28927341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    Schuettfort G; Groh A; Kann G; Haberl A; Herrmann E; Wetzstein N; Vehreschild MJGT; Stephan C
    HIV Med; 2023 Feb; 24(2):163-169. PubMed ID: 35859321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.